Article: article from journal or magazin.
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.
Journal of Viral Hepatitis
Jacobson I., Poordad F., Lawitz E., McCone J., Shiffman ML., Galler GW., Lee WM., Reindollar R., King J., Ghalib R., Freilich B., Nyberg LM., Goodman Z., Boparai N., Koury K., Brass CA.
Publication types: Journal Article ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Low-density lipoprotein cholesterol (LDL-C) levels and interleukin 28B (IL28B) polymorphism are associated with sustained viral response (SVR) to peginterferon/ribavirin (pegIFN/RBV) for chronic hepatitis C (CHC) infection. IL28B has been linked with LDL-C levels using a candidate gene approach, but it is not known whether other genetic variants are associated with LDL-C, nor how these factors definitively affect SVR. We assessed genetic predictors of serum lipid and triglyceride levels in 1604 patients with genotype 1 (G1) chronic hepatitis C virus (HCV) infection by genome-wide association study and developed multivariable predictive models of SVR. IL28B polymorphisms were the only common genetic variants associated with pretreatment LDL-C level in Caucasians (rs12980275, P = 4.7 × 10(-17), poor response IL28B variants associated with lower LDL-C). The association was dependent on HCV infection, IL28B genotype was no longer associated with LDL-C in SVR patients after treatment, while the association remained significant in non-SVR patients (P < 0.001). LDL-C was significantly associated with SVR for heterozygous IL28B genotype patients (P < 0.001) but not for homozygous genotypes. SVR modelling suggested that IL28B heterozygotes with LDL-C > 130 mg/dL and HCV RNA ≤600 000 IU/mL may anticipate cure rates >80%, while the absence of these two criteria was associated with an SVR rate of <35%. IL28B polymorphisms are the only common genetic variants associated with pretreatment LDL-C in G1-HCV. LDL-C remains significantly associated with SVR for heterozygous IL28B genotype patients, where LDL-C and HCV RNA burden may identify those patients with high or low likelihood of cure with pegIFN/RBV therapy.
Adult, Antiviral Agents/administration & dosage, Cholesterol, LDL/blood, Female, Genetic Association Studies, Genotype, Hepacivirus/classification, Hepacivirus/genetics, Hepatitis C, Chronic/drug therapy, Hepatitis C, Chronic/virology, Humans, Interferons/administration & dosage, Interleukins/genetics, Male, Middle Aged, Polymorphism, Genetic, Ribavirin/administration & dosage, Treatment Outcome, Viral Load
Web of science
Last modification date